 Alitretinoin is not indicated when systemic therapy against Kaposi's sarcoma is required.It has received EMA (11 October 2000) and FDA (2 March 1999) approval for this indication.Alitretinoin has been granted prescription rights in the UK (08/09/2008) for in chronic hand eczema as used by mouth.